CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
REVENUES:
License fees	$ 285,157	$ 382,767	$ 880,740	$ 1,094,843
Royalties from product sales	147,811	80,592	321,806	291,505
Grant income	647,580	160,431	1,863,310	941,226
Sale of research products and services	110,555	90,272	299,615	214,277
Total revenues	1,191,103	714,062	3,365,471	2,541,851
Cost of sales	(230,901)	(206,678)	(614,080)	(570,237)
Gross Profit	960,202	507,384	2,751,391	1,971,614
EXPENSES:
Research and development	(8,836,341)	(6,441,462)	(26,267,792)	(17,389,409)
General and administrative	(4,261,450)	(4,267,875)	(12,764,324)	(11,273,948)
Total operating expenses	(13,097,791)	(10,709,337)	(39,032,116)	(28,663,357)
Loss from operations	(12,137,589)	(10,201,953)	(36,280,725)	(26,691,743)
OTHER INCOME/(EXPENSES):
Interest (expense)/income, net (see Note 6)	(7,632)	509	(29,786)	2,033
(Loss)/gain on sale or write off of fixed assets	(133)	5,830	(8,709)	5,120
Other (expense)/income, net	(118,796)	(60,704)	165,135	(169,512)
Total other (expenses)/income, net	(126,561)	(54,365)	126,640	(162,359)
LOSS BEFORE INCOME TAX BENEFIT	(12,264,150)	(10,256,318)	(36,154,085)	(26,854,102)
Deferred income tax benefit	2,312,693	0	5,174,977	0
NET LOSS	(9,951,457)	(10,256,318)	(30,979,108)	(26,854,102)
Net loss attributable to noncontrolling interest	1,683,532	1,253,150	5,151,013	2,583,581
Net loss attributable to BioTime, Inc.	(8,267,925)	(9,003,168)	(25,828,095)	(24,270,521)
Dividends on preferred shares	(34,038)	0	(34,038)	0
Net loss attributable to common shareholders	(8,301,963)	(9,003,168)	(25,862,133)	(24,270,521)
Unrealized loss on available-for-sale assets	(1,210)	0	(2,740)	0
Foreign currency translation (loss)/gain	(66,768)	7,016	(216,330)	184,310
TOTAL COMPREHENSIVE NET LOSS	$ (8,335,903)	$ (8,996,152)	$ (26,047,165)	$ (24,086,211)
BASIC AND DILUTED NET LOSS PER COMMON SHARE (in dollars per share)	$ (0.12)	$ (0.16)	$ (0.41)	$ (0.45)
WEIGHTED AVERAGE NUMBER OF COMMON STOCK OUTSTANDING: BASIC AND DILUTED (in shares)	67,920,853	55,621,564	62,594,212	53,545,834